Gene · 4800
Papers1,566
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,566
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NFYA regulates the expression of CD44 via binding to upstream cis-element in breast cancer cells. | Biochimie | 2026 | 42749180 | PubTator, text mining | PubMed |
| Graph-Based Multi-Omics Integration Reveals Prognostic Histone Modification Reader Genes and Candidate Drug Targets in Colorectal Cancer. | Genes (Basel) | 2026 | 42650041 | PubTator, text mining | PubMed |
| Activation of EZH2 Promoter Is Mediated by MAPK Signaling Regulated Transcription Factors in Anaplastic Thyroid Cancer. | Int J Mol Sci | 2026 | 42511745 | PubTator, text mining | PubMed |
| HJURP upregulation, driven by transcription factor NFYA, promotes endometrial carcinoma progression via regulating RASSF8 ubiquitination. | Funct Integr Genomics | 2026 | 42321518 | PubTator, text mining | PubMed |
| Alternative Splicing of the NF-Y Subunit, NF-YA, in Neuroblastoma Phenotype Heterogeneity. | Cancers (Basel) | 2026 | 42279421 | PubTator, text mining | PubMed |
| NFYA Activates REG1A Expression to Promote Malignant Progression and Chemosensitivity in Rectal Cancer. | Ann Clin Lab Sci | 2026 | 42259544 | PubTator, text mining | PubMed |
| Single-nucleus and spatial transcriptomics analyses reveal interplay between evolutionary dynamics and energy metabolism in primary cardiac lymphoma. | Cancer Gene Ther | 2026 | 42174190 | PubTator, text mining | PubMed |
| NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer. | Cancers (Basel) | 2026 | 42122120 | PubTator, text mining | PubMed |
| BRD2 upregulation as a pan-cancer adaptive resistance mechanism to BET inhibition. | Cell Mol Biol Lett | 2026 | 42069518 | PubTator, text mining | PubMed |
| Sporozoite egress from Plasmodium oocysts requires a trimeric NF-Y-like complex. | Commun Biol | 2026 | 42045549 | PubTator, text mining | PubMed |
| Functional network analysis in hepatolithiasis: identifying novel therapeutic targets through whole-exome sequencing. | PeerJ | 2026 | 41978884 | PubTator, text mining | PubMed |
| NFYA regulates two sequential genome-wide transcriptional activation events during oocyte to embryo transition. | bioRxiv | 2026 | 41959188 | PubTator, text mining | PubMed |
| In Silico Discovery and Characterization of a Novel Nuclear Transcription Factor-Y (NF-Y) Inhibitor with Antimitogenic Properties. | J Med Chem | 2026 | 41858057 | PubTator, text mining | PubMed |
| The dual role of BRD9 in cancer: Mechanistic insights and therapeutic prospects. | iScience | 2026 | 41797932 | PubTator, text mining | PubMed |
| Temporal Transcriptomic and Metabolomic Reprogramming Unveils a Two-Phase Salt Tolerance Mechanism in Apocynum venetum. | Int J Mol Sci | 2026 | 41752054 | PubTator, text mining | PubMed |
| Precision Biomarker Identification in Gynecological Cancers Using Coexpression Networks and Attention-Based LSTM in Healthcare 4.0. | Diagnostics (Basel) | 2026 | 41750695 | PubTator, text mining | PubMed |
| OGG1 and MUTYH DNA Glycosylases, the Dynamic Duo Against 8-Oxoguanine DNA Lesion: Structure, Regulation, and Novel Emerging Roles. | Biomolecules | 2026 | 41750327 | PubTator, text mining | PubMed |
| Transcriptomics and Metabolomics Analysis Reveal the Mechanism of Petal Number Variation in Gardenia jasminoides. | Metabolites | 2026 | 41745611 | PubTator, text mining | PubMed |
| Identification and validation of paraptosis-related prognostic biomarkers in lung adenocarcinoma: An observational study based on transcriptomics and clinical outcomes. | Medicine (Baltimore) | 2026 | 41731832 | PubTator, text mining | PubMed |
| scTELL: a single-cell ATAC-seq tool for locus-specific transposable element identification in chromatin accessibility. | Mob DNA | 2026 | 41731605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4800/papers